돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 79501생성일: 2026년 10월 27일

5,6-Diamino-1,3-dimethyluracil

5,6-DIAMINO-1,3-DIMETHYLPYRIMIDINE-2,4(1H,3H)-DIONE · NSC 15493 · 2,4(1H,3H) · Doxofylline Impurity 19 · Theophylline Impurities 1 · 5,6-Diamino-1,3-dimethylurea · 4,5-DIAMINO-1,3-DIMETHYLURACIL · 1,3-DIMETHYL-5,6-DIAMINOURACIL

https://huagongshe.com/ko/chemical/79501

5,6-Diamino-1,3-dimethyluracil 분자 구조식

식별자 및 물리적 특성

CAS No.5440-00-6
분자식C6H10N4O2
평균 분자량170.17 g/mol
단동위원소 질량170.08037557 g/mol
SMILESCn1c(N)c(N)c(=O)n(C)c1=O
InChIKeyBGQNOPFTJROKJE-UHFFFAOYSA-N
PubChem CID79501
EC No.226-621-9
DTXSIDDTXSID8063886

화학 및 물리적 성질

XLogP-0.5
극성 표면적92.7
수소 결합 공여자 수2
수소 결합 수용자 수4
회전 가능 결합 수0
무거운 원자 수12
형식 전하0
복잡도283
녹는점210-214 °C (dec.)(lit.)
끓는 점243.6±50.0℃ (760 Torr)
밀도1.350±0.06 g/cm3 (20 ºC 760 Torr)
인화점101.1±30.1℃
저장 조건2-30°C
용해도DMSO및메탄올에 용해됨
물리적 상태고체
pKa(산도 계수)4.42±0.70(Predicted)
색상옅은 갈색
BRN157451
InChI1S/C6H10N4O2.H2O/c1-9-4(8)3(7)5(11)10(2)6(9)12/h7-8H2,1-2H31H2
InChIKeyFNLDCZCNGSQKIC-UHFFFAOYSA-N
SMILESO.CN1C(N)=C(N)C(=O)N(C)C1=O
EPA2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1,3-dimethyl- (5440-00-6)

화학적 성질

Pale Brown Solid

안전 및 규제

GHS 분류WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposureRespiratory tract irritation]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Hazard Classes and CategoriesAcute Tox. 4 (100%)Skin Irrit. 2 (100%)Eye Irrit. 2A (100%)STOT SE 3 (100%)
수질 위해 등급(WGK)3
TSCA 등재 상태TSCA listed
F 고인화성물질10-34
저장 분류11 - Combustible Solids

용도

용도

5,6-Diamino-1,3-dimethyluracil hydrate can be used as reactant involved in the synthesis of biologically active molecules including: 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands ; Pyrimidinyl purinediones via cyclocondensation ; Theophylline derivatives as adenosine receptor antagonists ; Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors ; Fused tricyclic xanthines and Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells6.